Is labetalol really a culprit in neonatal hypoglycaemia?

Archives of disease in childhood. Fetal and neonatal edition

Volumn 98, Issue 2, 2013, Pages

  Daskas, Nikolaos ^a   Crowne, Elizabeth ^a   Shield, Julian P H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LABETALOL;

CHEMICALLY INDUCED DISORDER; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; LETTER; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIA; INFANT, NEWBORN; LABETALOL; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 85027920316     PISSN: None     EISSN: 14682052     Source Type: None    
DOI: 10.1136/archdischild-2012-303057     Document Type: Letter

References (0)